v3 Template
V

Verona Pharma

Biopharmaceutical London and Raleigh, N.C. ~380 employees
Founded
--
Employees (Est.)
~380
19 leaders known
Total Funding
$1.5B
Funding Rounds
3
Last Funding
2025-03-28

About Verona Pharma

Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative prescription medicines for the treatment of chronic respiratory diseases, aiming to improve the health and wellbeing of affected individuals.

Products & Services

Ohtuvayre (ensifentrine):A first-in-class COPD maintenance treatment for adults, recently approved by the US FDA.
Development Programs:A broad portfolio of respiratory therapeutics in the pipeline targeting various chronic lung conditions.

Specialties

Respiratory therapeutics Chronic obstructive pulmonary disease (COPD) Non-Cystic Fibrosis Bronchiectasis Cystic Fibrosis Asthma

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 450000000
MR: -
FA: $450 million
FAN: 450000000
D: 2025-03-28
FD: 2025-03-28
2 investors
2 RT: Strategic Financing (Debt and Revenue Interest Purchase and Sale Agreement)
T: -
FT: Strategic Financing (Debt and Revenue Interest Purchase and Sale Agreement)
A: 650000000
MR: -
FA: $650 million
FAN: 650000000
D: 2024-05-09
FD: 2024-05-09
2 investors
3 RT: Debt
T: -
FT: Debt
A: 400000000
MR: -
FA: up to $400 million
FAN: 400000000
D: 2024-01-02
FD: 2024-01-02
2 investors
Debt Latest
2025-03-28
$450.0M
2 investors (Pro only)
Strategic Financing (Debt and Revenue Interest Purchase and Sale Agreement) 2024-05-09
$650.0M
Debt 2024-01-02
$400.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

David Zaccardelli

President and Chief Executive Officer

K

Kathleen Rickard

Chief Medical Officer

M

Mark W. Hahn

Chief Financial Officer

A

Andrew Fisher

General Counsel

T

Tara Rheault

Chief Development Officer

C

Christopher Martin

Chief Commercial Officer

View 16 more team members with Pro

Unlock Full Team Directory

Recent News

Verona Pharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~380 employees (est.)
Locations
London and Raleigh, N.C.
London, UK and Raleigh, NC, USA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro